Therapeutic choices of penile erectile dysfunction.
- Author:
Wen-Jun BAI
1
;
Xiao-Feng WANG
;
Xi-Tao JIANG
;
Hong-Wei QU
;
Ji-Chuan ZHU
Author Information
- Publication Type:Clinical Trial
- MeSH: Administration, Oral; Adult; Aged; Alprostadil; therapeutic use; Combined Modality Therapy; Erectile Dysfunction; drug therapy; therapy; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; therapeutic use; Piperazines; therapeutic use; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Testosterone; therapeutic use; Treatment Outcome; Vasodilator Agents; therapeutic use
- From: National Journal of Andrology 2002;8(5):332-334
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVESTo discuss the therapeutic choices of erectile dysfunction (ED) and to improve the therapeutic efficacy for different ED cases.
METHODSTwo hundred and twenty-seven patients with ED were treated repectively with psychological treatment(31 cases), oral testosterone(30 cases), Viagra(121 cases), psychological treatment + Viagra (16 cases), intraurethral PGE1 (8 cases) and intracavemous injection(21 cases).
RESULTSAmong those ED patients, 142 (62.6%) cases reported improved erections after they had undergone above-mentioned therapies. The improved patients include 12 cases(38.7%) with psychological treatment, 9 cases (30.0%) with oral testosterone, 91 cases (75.2%) with Viagra, 13 cases (81.3%) with psychological and Viagar, 2 cases (25.0%) with intraurethral PGE1 and 21 cases (71.4%) with intracavemous injection.
CONCLUSIONSED is a highly individualized disease, therapeutic choices of ED based on patient's situation can benefit those patients.
